ISB News

Aitchison Lab Accepts ALS Ice Bucket Challenge

Jennifer Smith, senior research scientist in the John Aitchison Lab, was tagged to do the ALS Ice Bucket Challenge. And because the Aitchison group studies ALS, Jennifer’s lab mates took the challenge, too. Jennifer offered this description of the work they are doing to create a blood test for early detection of ALS:

ISB is developing a multi-component blood-based assay (blood test) for early detection and disease tracking of ALS. We are doing this because there are no good diagnostic tests for ALS and, on average, it takes a year to get a definitive diagnosis, resulting in significant loss of therapeutic opportunity. There is a dire need for a robust and quantitative blood biomarker assay to help confirm initial diagnosis of ALS and to track disease activity not only for clinical use, but to also to develop new therapies for the disease.

The assay we are developing is called the indicator cell assay platform (iCAP) for blood-based diagnostics that can be used for early detection of ALS, and as a diagnostic tool for drug development. The iCAP uses cultured cells as biosensors, capitalizing on the natural ability of cells to detect signals present in serum from patients with ALS with exquisite sensitivity, as opposed to traditional assays that rely on direct detection of molecules in blood.

You can support ALSA.org to raise awareness about ALS. Or you can support ALS research directly with a gift to Institute for Systems Biology. Support ALS research directly.

You Have 24 Hours to Accept the Challenge!

And now, the Aitchison Lab challenges the following groups:

  • Mike Rout Lab, The Rockefeller University
  • Alan Aderem Lab, Seattle BioMed
  • Dave Goodlett Lab, University of Maryland

Learn more about the Aitchison Lab and Jennifer Smith. Jennifer received a “proof of concept” grant from the Life Sciences Discovery Fund to develop a similar early detection test for Alzheimer’s.

Ice Bucket Challenge Photo Gallery

You may also visit the full gallery on Flickr.

ALS5614 ALS5615 ALS5616

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.